ALDH1A1 and non-small cell lung carcinoma: Similarly, the isolated ALDH1+ve fractions showed a significantly increased clonogenic survival ability at increasing concentrations of cisplatin (1-10μM) compared to the ALDH1-ve fractions across each of the NSCLC cell lines of different histological subtypes (Figure 3B).